These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 14426658

  • 21. Clinical and biochemical studies of an amphetamine withdrawal psychosis.
    YOUNG GG, SIMSON CB, FROHMAN CE.
    J Nerv Ment Dis; 1961 Mar; 132():234-8. PubMed ID: 13787461
    [No Abstract] [Full Text] [Related]

  • 22. Psychosis Risk With Prescription Amphetamine.
    Tamminga CA.
    Am J Psychiatry; 2024 Oct 01; 181(10):856-857. PubMed ID: 39350617
    [No Abstract] [Full Text] [Related]

  • 23. A case of recurrent psychosis associated with amphetamine addiction.
    O'FLANAGAN PM, TAYLOR RB.
    J Ment Sci; 1950 Oct 01; 96(405):1033-6. PubMed ID: 14804039
    [No Abstract] [Full Text] [Related]

  • 24. Factors involved in drug-produced model psychoses.
    FISCHER R.
    J Ment Sci; 1954 Jul 01; 100(420):623-31. PubMed ID: 13192462
    [No Abstract] [Full Text] [Related]

  • 25. [Does chronic psychosis due to amphetamines abuse exist? Study of 25 drug addicts].
    Charles-Nicolas AJ.
    Nouv Presse Med; 1976 Nov 06; 5(37):2447-50. PubMed ID: 980758
    [Abstract] [Full Text] [Related]

  • 26. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?
    Dalmau A, Bergman B, Brismar B.
    Eur Psychiatry; 1999 Nov 06; 14(7):366-71. PubMed ID: 10683620
    [Abstract] [Full Text] [Related]

  • 27. Psychosis induced by amphetamines.
    Bramness JG, Rognli EB.
    Curr Opin Psychiatry; 2016 Jul 06; 29(4):236-41. PubMed ID: 27175554
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Bromide psychosis].
    BORG E, NOREIK K.
    Tidsskr Nor Laegeforen; 1959 Nov 01; 79():1242-4. PubMed ID: 13802782
    [No Abstract] [Full Text] [Related]

  • 35. [On psychotic manifestations following INH withdrawal].
    GRAHMANN H, PETERS UH.
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1962 Nov 01; 203():173-7. PubMed ID: 13901045
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Antabuse psychosis as a consequence of an error in dosage?].
    HVAM T.
    Ugeskr Laeger; 1960 Jun 30; 122():893-4. PubMed ID: 14405679
    [No Abstract] [Full Text] [Related]

  • 38. [Neurological and psychiatric findings in Cycloserine therapy].
    KUNCOVA S, VOJIR R, DOMINEC M.
    Act Nerv Super (Praha); 1962 Jun 30; 4():234-5. PubMed ID: 14460535
    [No Abstract] [Full Text] [Related]

  • 39. [Model psychoses and their significance for an improved understanding of endogenous and exogenous psychoses].
    HAASE HJ.
    Med Klin; 1956 Nov 02; 51(44):1881-3. PubMed ID: 13386826
    [No Abstract] [Full Text] [Related]

  • 40. [Influenzal psychoses].
    PORTA V.
    Arch Psicol Neurol Psichiatr; 1959 Nov 02; 20():239-63. PubMed ID: 14434254
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.